

MSD Animal Health Completes Acquisition of IdentiGEN

05/08/2020
Deals
Arthur Cox is very pleased to have partnered with Gibson, Dunn & Crutcher LLP in advising MSD Animal Health, a division of Merck & Co., Inc., on its acquisition of IdentiGEN, a leading provider of DNA-based solutions to the agri-food industry with operations in Ireland, UK, Europe, USA and Canada.
The Arthur Cox team was led by Michael Coyle (Corporate and M&A) and included Conor O’Keeffe and Ailbhe Ní Bhriain (Corporate and M&A), Orlaith Kane (Tax), Grace Gannon (Employment), Michael Shovlin (Pensions), Ian Duffy (IP/IT) and Lucy Byrne (Real Estate).
Read more here.